Professor Jacqui Matthews
Austin Davis Biologics Ltd (ADB) Announce The Appointment Of Professor Jacqui Matthews As Director Of Veterinary Science
26th September, 2022 12h29
Austin Davis Biologics Ltd (ADB), service providers of EquiSal Tapeworm saliva testing and equine parasitology blood tests, are very excited to announce the appointment of Professor Jacqui Matthews, as Director of Veterinary Science, effective from 14th November 2022.
In this role, Professor Matthews will lead ADB’s R&D activities, overseeing the company’s development pipeline in veterinary diagnostics, together with fundamental parasitology research utilising ADB’s commercially available tests for continuous development and improvements. Professor Matthews will also provide expert advice and support to users of the diagnostic test services through webinars and other training activities.
Originally qualifying as veterinary surgeon, Professor Matthews moved into academia, and, over the next 25 years, developed an international profile in animal science, leading a range of national and international interdisciplinary research projects. Professor Matthews is a world renowned equine parasitologist, holding the prestigious qualification of ‘Royal College of Veterinary Surgeons Recognised Specialist in Parasitology’. She has published over 140 peer-reviewed papers, and most notably is the inventor of the small redworm blood test, commercialised by ADB in 2019.
Professor Jacqui Matthews says, “I am absolutely delighted to be joining ADB and given this opportunity to support and promote evidence based helminth control in horses in the UK and overseas. I am also really looking forward to bringing more innovative diagnostics to the market to support animal health”.
Dr Corrine Austin, Founder and Managing Director of ADB, commented, “we are thrilled that Professor Matthews is joining our family-run veterinary diagnostic company. Her input to ADB’s research programmes, as well as the wider equine parasitology field, is highly valued. Not only do we have a busy future research program, but we hold a lot of information that hasn’t yet been published; Jacqui’s new position within ADB will accelerate future research as well dissemination of our existing research data.
More from Austin Davis Biologics Ltd
- Tapeworm should be considered a significant pathogen in young horses: findings presented at recent equine colic symposium
- Research paper published for Equine Small Redworm Blood Test
- Large reduction in anthelmintic use achieved with targeted tapeworm control strategy: research published by EVJ